Allurion Technologies has launched AllurionMeds, a novel approach to weight management that combines affordable weight loss medication with an advanced AI-driven platform. The platform, which includes AI Coach Iris, offers virtual access to dietitians and a connected smart scale that assesses weight, muscle, and bone composition. Dr. Shantanu Gaur, the Founder and CEO of Allurion, underscored that AllurionMeds is intended to assist patients in losing weight and maintaining their progress, thereby addressing critical issues such as high healthcare costs, poor medication adherence, and muscle mass loss. The program guarantees comprehensive monitoring and support for patients by providing access to the Allurion Connected Scale and a GLP-1 companion app.
The launch of AllurionMeds expands Allurion's product offerings to all 50 states in the U.S. The company's decade-long experience with over 150,000 patients has informed the development of this AI-native platform, which aims to provide a best-in-class experience for GLP-1 users. Patients will receive GLP-1 drugs from an FDA-registered facility and benefit from 24/7 AI-powered coaching. Allurion Technologies is renowned for its weight loss solutions, including the Allurion Gastric Balloon and the Allurion Virtual Care Suite. The company continues to advance its mission to end obesity by offering integrated, patient-centered care and innovative weight management tools.
